For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Spark looks to bring latest tech to practices
Wednesday 10 April 2024, 01:25 AM

Spark Health chief executive John Macaskill-Smith [Image: Supplied]
Stephen Forbes unveils the healthcare vision and potential expansion plans of Spark Health, a subsidiary of the telecommunications heavyweight
John Macaskill-Smith was appointed Spark Health’s chief executive in September last year.
Previously the chief network officer at Tend Health, Mr M
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.